Home » Newsletters » BioWorld Science

BioWorld Science

June 29, 2018

View Archived Issues

The locus of alcohol's reward

GBM cells spread their message beyond death

FDA clears of IND application for OC-01 as treatment of dry eye disease

Kangpu initiates phase I study of KPG-121 for metastatic CRPC

Inovio reports phase I results for INO-4700 in MERS

Erimos Pharmaceuticals initiates phase I study of oral terameprocol

Preliminary data presented from the PIVOT-02 study of NKTR-214 plus nivolumab

Enrollment begins in phase IIa study of CC-31244 for the treatment of HCV-infected individuals

Efficacy unclear in study of mutated IDH1 peptide vaccine in patients with gliomas

Akebia Therapeutics and Keryx Biopharmaceuticals sign definitive merger agreement

Melinta Therapeutics describes leads from the pyrrolocytosine class of antibiotics

Kymab to test KY-1044 in combination with atezolizumab in clinical trials

Researchers present preclinical data for [11C]NOP-46

European Commission approves Xeljanz for active psoriatic arthritis

Arsanis discontinues phase II study of ASN-100

Ziopharm initiates phase I trial of Ad-RTS-hIL-12 plus veledimex with nivolumab in recurrent GBM

INDIGO-1 study of gemcabene in severe hypertriglyceridemia meets primary endpoint

Trevena completes first-in-human study of TRV-250 for treatment of acute migraine

ProQR initiates phase I/II WINGS trial of QR-313

Phase III MEDALIST study of luspatercept meets primary and key secondary endpoints

EMA committee recommends approval of Cablivi for aTTP

New MAP4K1 inhibitors identified at Ariad Pharmaceuticals

FUJIFILM, Nagoya City University patent flycosylated chlorin e6 derivatives

Aclaris reports promising interim data from phase II trial of ATI-501 in severe alopecia areata

Preliminary in vivo pharmacokinetics for [125I]p93 reported

Novartis to spin off Alcon eye care devices business

Japan Tobacco and Torii Pharmaceutical discontinue development of JTS-661

G1T38 demonstrates safety and early evidence of antitumor activity in breast cancer

First-in-human results presented from VANCE study of ChAdOx1-MVA 5T4 vaccine

Galapagos reports topline results for GLPG-2737, updates triple combination plans in cystic fibrosis

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 19, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 19, 2025.
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.
ABS-1230 controls seizures in KCNT1-driven severe epilepsy
BioWorld Science
Mutations in the KCNT1 gene produce gain-of-function effects that lead to overactivation of the potassium channel and consequent disruption of normal neuronal...